← Eichor
Study identifier: NCT05342233 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Conservative and Endovascular Treatment for Spontaneously Isolated Superior Mesenteric Artery Dissection

Condition: Spontaneous Isolated Superior Mesenteric Artery Dissection  ·  Sponsor: Xiangya Hospital of Central South University

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Spontaneous isolated superior mesenteric artery dissection(SISMAD) is an increasingly diagnosed disease. However, prospective, multicenter studies that can provide evidence to support clinical decisions are very limited. This study aims to compare the therapeutic efficacy of conservative and endovascular treatment for SISMAD.

This description comes directly from the study's public registry record.

Talk to the study team

Wang WEI, Ph.D.  ·  13808482650  ·  weiwangcsu@csu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Xiangya Hospital of Central South UniversityChangsha, Hunan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05342233